Resources Contact Us Home
Formulation of quinazoline based EGFR inhibitors containing a zinc binding moiety

Image Number 13 for United States Patent #8119616.

The present invention relates to a composition comprising an inclusion complex of a cyclodextrin and quinazoline containing zinc-binding moiety based derivatives. The cyclodextrin is preferable a .beta.-cyclodextrin or a derivative thereof. The quinazolines have enhanced and unexpected properties as inhibitors of epidermal growth factor receptor tyrosine kinase (EGFR-TK) and their use in the treatment of EGFR-TK related diseases and disorders such as cancer. The said derivatives may further act as HDAC inhibitors.

  Recently Added Patents
Network traffic demotion
ZnO green luminescent material and its preparation
Scoring users of network based users
Head shield
Dynamic facsimile transcoding in a unified messaging platform
Light fixture
High-accuracy centered fractional fourier transform matrix for optical imaging and other applications
  Randomly Featured Patents
Method for forming a DRAM semiconductor device with a sense amplifier
Tail lens assembly
Substrate with slot
Radial pump
Continuously cast steel slabs for steel sheets having excellent workabilities and method for production thereof
Substrate treating apparatus, and a substrate transporting method therefor
Adjustable pole-mounted mail box support
Conching device
Horizontal ornamental hand sign with "--------'s on T.V."
HIV integrase inhibitors